Indian Pharma Industry
- All
- News
- Videos
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
-
Government Hopes This City Will Break China's Grip On Pharma Industry
On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
-
Indian Pharma Is Scaling Up Vaccine Plans For Local and Global Needs
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
India Capable Of Producing COVID-19 Vaccines For Entire World: Bill Gates
India's pharmaceutical industry will be able to produce COVID-19 vaccines not just for the country but also for the entire world, according to Microsoft co-founder and philanthropist Bill Gates.
-
Indian-Origin Drugs Firm Boss Banned For 5 Years For Price-Fixing In UK
An Indian-origin pharmaceutical industry chief has signed undertakings that ban him from holding a director role at any UK company for the next five years, in connection with his role in companies that were allegedly involved in illegal arrangements such as price-fixing of drugs.
-
LinkedIn Says Tech Jobs Are Fastest Growing for Indian Professionals
LinkedIn said tech jobs are in demand across sectors from pharma to banking and retail, and companies in these various industries see a high demand for talent in these roles.
-
Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian
Pharma tycoon Dilip Shanghvi today surpassed Mukesh Ambani as the world's richest Indian with a net worth of $21.5 billion -- within two days of Reliance Industries chief being ranked India's wealthiest for 8th year.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
-
Government Hopes This City Will Break China's Grip On Pharma Industry
On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
-
Indian Pharma Is Scaling Up Vaccine Plans For Local and Global Needs
India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
-
India Capable Of Producing COVID-19 Vaccines For Entire World: Bill Gates
India's pharmaceutical industry will be able to produce COVID-19 vaccines not just for the country but also for the entire world, according to Microsoft co-founder and philanthropist Bill Gates.
-
Indian-Origin Drugs Firm Boss Banned For 5 Years For Price-Fixing In UK
An Indian-origin pharmaceutical industry chief has signed undertakings that ban him from holding a director role at any UK company for the next five years, in connection with his role in companies that were allegedly involved in illegal arrangements such as price-fixing of drugs.
-
LinkedIn Says Tech Jobs Are Fastest Growing for Indian Professionals
LinkedIn said tech jobs are in demand across sectors from pharma to banking and retail, and companies in these various industries see a high demand for talent in these roles.
-
Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian
Pharma tycoon Dilip Shanghvi today surpassed Mukesh Ambani as the world's richest Indian with a net worth of $21.5 billion -- within two days of Reliance Industries chief being ranked India's wealthiest for 8th year.
